IIS La Fe
Method for predicting cardiotoxicity risk in cancer patients receiving anthracyclines chemotherapy
Biomarkers / Diagnostic
Cancer
Cardiovascular and circulatory systems
In vitro method for predicting cardiotoxicity risk in a cancer patient receiving, or susceptible to receive, anthracyclines chemotherapy 5 based on the determination of the expression levels of a combination of 10 circulating miRNAs
2Preclinical Validation,
1R+D